Robert R. Bies, PhD | Psychiatrist.com

Article

Increasing Versus Maintaining the Dose of Olanzapine or Risperidone in Schizophrenia Patients Who Did Not Respond to a Modest Dosage: A Double-Blind Randomized Controlled Trial

October 26, 2016

When your patients with schizophrenia insufficiently respond to antipsychotic treatment, do you increase the dose? Do you check their plasma drug concentration? Read this CME article to find out...

Hitoshi Sakurai, Takefumi Suzuki, Robert R. Bies, et al

Original Research

Dose Reduction of Risperidone and Olanzapine and Estimated Dopamine D2 Receptor Occupancy in Stable Patients With Schizophrenia: Findings From an Open-Label, Randomized, Controlled Study

July 22, 2014

Hiroyoshi Takeuchi, Takefumi Suzuki, Robert R. Bies, et al

Original Research

Impact of Once- Versus Twice-Daily Perphenazine Dosing on Clinical Outcomes: An Analysis of the CATIE Data

May 15, 2014

Hiroyoshi Takeuchi, Gagan Fervaha, Hiroyuki Uchida, et al